Calcilytix Therapeutics, Inc., A Bridgebio Company

This study tests a new drug called encaleret against standard treatments for people with a rare genetic condition that causes low blood calcium and high urine calcium. About 67 adults and teens will take part to see if encaleret can safely bring calcium levels into a healthy rang…

This study is for people with autosomal dominant hypocalcemia types 1 or 2, rare genetic conditions that cause low blood calcium. Researchers will collect past and future health data from 95 participants to better understand how the disease changes over time. The goal is to learn…